OssDsign AB (publ) (OSSD.ST)
SEK 13.94
(-2.65%)
SEK 13.94
(-2.65%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -162.78 Million SEK | -46.59% |
| 2022 | -111.05 Million SEK | 19.08% |
| 2021 | -137.23 Million SEK | -326.66% |
| 2020 | -32.16 Million SEK | 70.49% |
| 2019 | -108.99 Million SEK | -2250.46% |
| 2018 | -4.63 Million SEK | 81.57% |
| 2017 | -25.16 Million SEK | -101.99% |
| 2016 | -12.45 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -134.77 Million SEK | 17.21% |
| 2024 Q2 | -116.18 Million SEK | 13.79% |
| 2023 Q4 | -162.78 Million SEK | -20.92% |
| 2023 Q2 | -61.47 Million SEK | 25.7% |
| 2023 FY | -162.78 Million SEK | -46.59% |
| 2023 Q1 | -82.73 Million SEK | 25.5% |
| 2023 Q3 | -134.62 Million SEK | -119.01% |
| 2022 Q4 | -111.05 Million SEK | -49.34% |
| 2022 Q2 | -93.81 Million SEK | 15.72% |
| 2022 FY | -111.05 Million SEK | 19.08% |
| 2022 Q1 | -111.3 Million SEK | 18.89% |
| 2022 Q3 | -74.36 Million SEK | 20.73% |
| 2021 Q3 | -182.81 Million SEK | 24.41% |
| 2021 FY | -137.23 Million SEK | -326.66% |
| 2021 Q4 | -137.23 Million SEK | 24.93% |
| 2021 Q2 | -241.85 Million SEK | -2454.49% |
| 2021 Q1 | -9.46 Million SEK | 70.56% |
| 2020 Q2 | -58.95 Million SEK | 30.81% |
| 2020 FY | -32.16 Million SEK | 70.49% |
| 2020 Q3 | -37.13 Million SEK | 37.01% |
| 2020 Q1 | -85.2 Million SEK | 21.82% |
| 2020 Q4 | -32.16 Million SEK | 13.39% |
| 2019 Q3 | -132.41 Million SEK | 13.84% |
| 2019 Q1 | -28.04 Million SEK | -504.74% |
| 2019 FY | -108.99 Million SEK | -2250.46% |
| 2019 Q4 | -108.99 Million SEK | 17.69% |
| 2019 Q2 | -153.67 Million SEK | -448.03% |
| 2018 FY | -4.63 Million SEK | 81.57% |
| 2018 Q1 | 35.23 Million SEK | 0.0% |
| 2018 Q4 | -4.63 Million SEK | 0.0% |
| 2017 FY | -25.16 Million SEK | -101.99% |
| 2016 FY | -12.45 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | -363.137% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 113.268% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 113.268% |
| Arcoma AB | -1.12 Million SEK | -14331.56% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | 248.148% |
| BICO Group AB (publ) | 927.9 Million SEK | 117.544% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | 226.388% |
| CellaVision AB (publ) | -56.94 Million SEK | -185.884% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | -994.226% |
| Chordate Medical Holding AB (publ) | -8.45 Million SEK | -1825.298% |
| C-Rad AB (publ) | -127.6 Million SEK | -27.577% |
| Duearity AB (publ) | 10.23 Million SEK | 1691.125% |
| Dignitana AB (publ) | 13.07 Million SEK | 1344.842% |
| Episurf Medical AB (publ) | -52.7 Million SEK | -208.896% |
| Getinge AB (publ) | 5.4 Billion SEK | 103.01% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | -364.404% |
| Iconovo AB (publ) | -10.75 Million SEK | -1413.556% |
| Integrum AB (publ) | -10.47 Million SEK | -1453.834% |
| Luxbright AB (publ) | -13.83 Million SEK | -1076.769% |
| Mentice AB (publ) | -49.56 Million SEK | -228.44% |
| Paxman AB (publ) | -11.41 Million SEK | -1326.588% |
| Promimic AB (publ) | -50.32 Million SEK | -223.486% |
| Qlife Holding AB (publ) | 19.07 Million SEK | 953.634% |
| SciBase Holding AB (publ) | -27.32 Million SEK | -495.769% |
| ScandiDos AB (publ) | -1.53 Million SEK | -10532.789% |
| Sectra AB (publ) | -772.85 Million SEK | 78.937% |
| Sedana Medical AB (publ) | -226.87 Million SEK | 28.247% |
| Senzime AB (publ) | -139.54 Million SEK | -16.66% |
| SpectraCure AB (publ) | -50.23 Million SEK | -224.059% |
| Stille AB | -178.5 Million SEK | 8.804% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 113.256% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | 24.162% |